Abstract:Objectives We aim to explore the incidence and risk factors of AF, dangerous ventricular arrhythmias and bradyarrhythmia in patients with HCM, and improve the awareness of clinicians on hypertrophic cardiomyopathy (HCM) associated with life-threatening arrhythmias. Methods We retrospectively collected the clinical data of 86 unrelated patients diagnosed as HCM in our hospital from January 2009 to January 2012, including each patient9s personal characteristics, clinical manifestations, echocardiography, 12-lead electrocardiography(ECG), 24 h Holter ECG monitoring, coronary angiography, left ventricular angiography and related treatment. Results 1. In 86 patients with HCM, male and female patients were 56 and 30, respectively, and mean age was 58.4±14.3 years. 2. 21 patients (24.4%) had documented AF, 7 patients with paroxysmal AF and 14 patients with chronic AF. 72 patients (85.7%) had premature ventricular contractions (PVCs), 36 patients (41.9%) had PVCs with Low grade ≥3, and 22 patients (25.6%) had non-sustained ventricular tachycardia (NSVT). eight patients (9.3%) had sick sinus syndrome (SSS), 11 patients (12.8%) had atrioventricular block (AVB) and nine patients (10.5%) had atrial fibrillation with slow ventricular rate and long RR interval (RR interval >2.0 s). 3. The mean age at examination was 64.1±11.0 years in patients with AF, older than those with sinus rhythm (56.6±14.8 years) (p=0.037). Left atrial diameter (LAD) was greater in patients with AF than those without AF (45.3±5.2 mm vs 40.2±5.2 mm) (p<0.01). There were 8 cases (38.1%) in NYHA classes III and IV in AF group, more than those without AF (6.2%, p=0.001). And left ventricular ejection fraction (LVEF) in AF group was lower than those without AF (64.8±9.7% vs 69.4±8.1%, p=0.036). 4. Maximum left ventricular wall thickness (MLVWT) and LAD was greater in patients with dangerous ventricular arrhythmias (B group) than in patients without dangerous ventricular arrhythmias (A group) (23.1±5.4 mm vs 20.2±4.9 mm and 42.8±5.2 mm vs 40.4±5.8 mm, p=0.009 and 0.048, respectively). The incidence of AF in B group was significantly higher than in A group (36.1% vs 16.0%, p<0.05). 5. In patients with pacemaker implantation, the age (mean 67.6±7.4 years) was older than those without pacemaker implantation (mean 55.5±14.1 years, p=0.01). LVEF in patients with pacemaker implantation was significantly lower than in patients without pacemaker implantation (64.0±10.0% vs 69.3±8.1%, p=0.024). And the incidence of AF in patients with pacemaker implantation was significantly higher than in patients without pacemaker implantation (52.9% vs 17.4%, p<0.05). Conclusions Our study showed the incidence of arrhythmias in patients with HCM, including AF, dangerous ventricular arrhythmias and bradyarrhythmia, was quite high. And the incidence of AF and bradyarrhythmia was positively correlated with age increasing. The occurrence of AF was significantly associated with LAD, cardiac dysfunction and age. The prevalence of dangerous ventricular arrhythmias was 41.9%, and its occurrence was associated with MLVWT and LAD. LVEF was significantly decreased in patients with pacemaker implantation. The prevalence of AF in patients with dangerous ventricular arrhythmias and bradyarrhythmia was much higher than others without dangerous ventricular arrhythmias and bradyarrhythmia. Therefore, AF might play an important role in the prognosis of HCM patients.

Occurrence of Cardiac Arrhythmia after Artificial Cardiac Pacemaker Double Helixelectrode Implantation and Its Influencing Factor Analysis

Analysis of Clinical Application of Magnetic Compatible Cardiac Implantable Electronic Device in a Chinese Population

Cardiac Pacemaker Survey-Twenty Hospitals Pacemaker Implantation Registry in China

The Use of Artificial Intelligence for Detecting and Predicting Atrial Arrhythmias Post Catheter Ablation

Correlation analysis of risk factors of atrial fibrillation after artificial cardiac pacemaker implantation

Predicting factors of heart arrhythmia in patients with permanent heart pacemaker

ANALYSIS OF PREDICTORS OF ATRIAL FIBRILLATION AFTER PACEMAKER IMPLANTATION

Multivariable analysis of incident ventricular tachycardia or ventricular fibrillation in patients with implantable cardioverter defibrillator

The incidence and risk factors of atrial high-rate episodes in patients with a dual-chamber pacemaker

Atrial High-Rate Event Incidence and Predictors in Patients With Permanent Pacemaker Implantation

Effect of heart pacemaker on preventing and terminating chronic arrhythmia and its influence on cardiac function

Relationship Between the Change in Pacing Threshold and the Myocardial Injury.

The Clinical Observation of Auto AV Search Algorithm in Dual Chamber Pacemaker.

Progression of Device-Detected Atrial High-Rate Episodes and the Risk of All-Cause Mortality

Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death: a single center experience

Analysis of Early Warning Diagnostic Indexes and Influencing Factors of Anxiety and Depression in Patients with Arrhythmia

PREVALENCE AND RELATED FACTORS OF ARRHYTHMIAS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY

Nervous dysfunction in the procedure of pacemaker implantation

A retrospective study of atrial fibrillation after DDD pacemaker implantation

The Analysis and Discussion of Arrhythmia with Related Factors and Clinical Features in Old Patients

Analysis of complications after pacemaker implantation 82 cases